tiprankstipranks
Advertisement
Advertisement

HIND Stock Latest News

Vyome Holdings to present Phase 2 data on VT-1953 at AACR 2026
The FlyVyome Holdings to present Phase 2 data on VT-1953 at AACR 2026
9d ago
HIND
Vyome Holdings reports FY25 revenue $319.7k vs $246.9k last year
PremiumThe Fly
Vyome Holdings reports FY25 revenue $319.7k vs $246.9k last year
20d ago
HIND
Vyome’s Livechain Acquires Humanyze to Expand AI HR Analytics
PremiumCompany Announcements
Vyome’s Livechain Acquires Humanyze to Expand AI HR Analytics
2M ago
8K
HIND
Vyome Holdings publishes preclinical VT-1908 data
PremiumThe Fly
Vyome Holdings publishes preclinical VT-1908 data
2M ago
HIND
Vyome Reports Positive Phase 2 Data for VT-1953 Gel
PremiumCompany Announcements
Vyome Reports Positive Phase 2 Data for VT-1953 Gel
2M ago
8K
HIND
Vyome Holdings funds budget for VT-1953 study
PremiumThe FlyVyome Holdings funds budget for VT-1953 study
2M ago
HIND
Vyome Holdings Highlights VT-1953 Market Potential Analysis
Premium
Company Announcements
Vyome Holdings Highlights VT-1953 Market Potential Analysis
3M ago
8K
HIND
Vyome’s LiveChain Signs LOI for Humanyze Note Acquisition
Premium
Company Announcements
Vyome’s LiveChain Signs LOI for Humanyze Note Acquisition
4M ago
8K
HIND
Vyome Holdings: Promising Advancements in MFW Treatment and Strategic Market Positioning Drive Buy Rating
PremiumRatings
Vyome Holdings: Promising Advancements in MFW Treatment and Strategic Market Positioning Drive Buy Rating
4M ago
HIND
Vyome Holdings announces VT-1953 trial achieves primary, secondary endpoints
PremiumThe Fly
Vyome Holdings announces VT-1953 trial achieves primary, secondary endpoints
4M ago
HIND
Vyome Holdings Inc. Reports Post-Merger Financials
PremiumCompany Announcements
Vyome Holdings Inc. Reports Post-Merger Financials
5M ago
HIND
Vyome Holdings: Buy Rating Backed by Promising Pipeline and Strategic Growth Potential
PremiumRatings
Vyome Holdings: Buy Rating Backed by Promising Pipeline and Strategic Growth Potential
5M ago
HIND
Vyome Holdings files to sell 610K shares of common stock for holders
PremiumThe FlyVyome Holdings files to sell 610K shares of common stock for holders
5M ago
HIND
Vyome Holdings Elects Directors at Annual Meeting
Premium
Company Announcements
Vyome Holdings Elects Directors at Annual Meeting
6M ago
8K
HIND
Vyome Holdings Acquires AI Startup Oculo, Inc.
Premium
Company Announcements
Vyome Holdings Acquires AI Startup Oculo, Inc.
6M ago
8K
HIND
Vyome Holdings upgraded to Buy at Maxim on immuno-inflammatory pipeline
PremiumThe Fly
Vyome Holdings upgraded to Buy at Maxim on immuno-inflammatory pipeline
7M ago
HIND
Vyome Holdings upgraded to Buy from Hold at Maxim
PremiumThe Fly
Vyome Holdings upgraded to Buy from Hold at Maxim
7M ago
HIND
Vyome Holdings acquires MIT AI spinout Oculo Health
PremiumThe Fly
Vyome Holdings acquires MIT AI spinout Oculo Health
7M ago
HIND
Morning News Wrap-Up: Wednesday’s Biggest Stock Market Stories!
PremiumMarket News
Morning News Wrap-Up: Wednesday’s Biggest Stock Market Stories!
7M ago
EA
AMD
Vyome Stock (HIND) Rockets on Uveitis Study Data
PremiumMarket NewsVyome Stock (HIND) Rockets on Uveitis Study Data
7M ago
HIND
Vyome Holdings presents results from VT-1908 preclinical studies
Premium
The Fly
Vyome Holdings presents results from VT-1908 preclinical studies
7M ago
HIND
Vyome Holdings appoints Richard Fahrner as CTO
Premium
The Fly
Vyome Holdings appoints Richard Fahrner as CTO
7M ago
HIND

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >